Midwest Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Midwest Trust's VRTX Position: Q2 2026 in Review

Midwest Trust increased its Vertex Pharmaceuticals (VRTX) stake by 3.8% in Q2 2026, buying an estimated $10.2K and bringing the position to 621 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Midwest Trust first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Midwest Trust held 621 shares of Vertex Pharmaceuticals worth $308K as of Q2 2026.
• Midwest Trust bought 23 Vertex Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
• Vertex Pharmaceuticals made up ﹤0.01% of Midwest Trust's portfolio in Q2 2026, its #526 holding.
• Midwest Trust first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
• 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.